Efficacy of levetiracetam for neonatal seizures in preterm infants
Abstract Background Neonatal seizures remain a significant clinical problem, and therapeutic options are still not diverse with limited efficacy. Levetiracetam (LEV) is a relatively new and wide spectrum anti-seizure medication with favorable pharmacokinetics and safety profile. In the recent decade...
Saved in:
Main Authors: | Ji Yoon Han (Author), Chung Joon Moon (Author), Young Ah Youn (Author), In Kyung Sung (Author), In Goo Lee (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience and pharmacokinetics of Levetiracetam in Korean neonates with neonatal seizures
by: Jae Won Shin, et al.
Published: (2017) -
Levetiracetam as the First-line Antiepileptic in Neonatal Seizures
by: Hari Prasath Ramachandran, et al.
Published: (2020) -
Levetiracetam in Partial Seizures
by: J Gordon Millichap
Published: (2002) -
Efficacy of levetiracetam in refractory childhood epilepsy
by: Keon Su Lee, et al.
Published: (2010) -
Levetiracetam for Pediatric Posttraumatic Seizure Prophylaxis
by: Dragos A. Nita, et al.
Published: (2016)